Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellect Biotechnology Ltd. (a foreign private issuer) covers the month of June 2018. The report addresses a corporate governance event regarding the Company's Annual General Meeting (AGM).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice and does not contain financial statements or performance data.
Material Changes
There are no material financial changes reported. The only material event disclosed is the adjournment of the AGM originally scheduled for June 28, 2018, due to a lack of quorum.
Outlook, Risks, and Management Commentary
Management has reconvened the Annual General Meeting for Thursday, July 5, 2018, at 11:00 a.m. (Israel time). The meeting will be held at the offices of Doron, Tikotzky, Kantor, Gutman & Amit Gross, located at B.S.R 4 Tower, 33rd Floor, 7 Metsada Street, Bnei Brak, Israel. No specific risks, contingencies, or unusual items were disclosed in this text.
Key Facts for Investor Verification
- The AGM scheduled for June 28, 2018, failed to achieve a quorum.
- The AGM has been rescheduled for July 5, 2018, at the same time and location.
- No financial results or operational updates are included in this specific filing.